EP1908477A3

Combination of temozolomide and pegylated interferon-alpha for treating cancer

Abstract

A method for treating a human patient afflicted with cancer, comprising administering therapeutically effective amounts of temozolomide and pegylated interferon alpha to such a patient.

Term

Term ended

Projected expiry passed 22 January 2021, 5.7 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

Every citation, both ways

Citations
DocumentRelationOfficeCategoryCited duringRelevant claims
EP0593868A1CitesEuropean Patent Office (EPO)YSearch report1-22
EP0809996A2CitesEuropean Patent Office (EPO)YSearch report1-22
WO9513090A1CitesWorld Intellectual Property Organization (WIPO)YSearch report1-22
WO9712630A1CitesWorld Intellectual Property Organization (WIPO)YSearch report1-22
WO9948535A1CitesWorld Intellectual Property Organization (WIPO)YSearch report1-22